State governments in 2011 continued to see regional economic growth in the life sciences industry and in 2012 will increasingly focus attention on technology transfer and venture funding as mechanisms to increase private sector innovation related activities within their jurisdictions. Realizing that entrepreneurship is a key ingredient in economic development, states and localities are undertaking the support of programs that assist high technology businesses, and that capitalize on state regional presence of universities and federal laboratories.

The 2011 Biotechnology Institute International BioGENEius Challenge winner will present at the White House Science Fair taking place this week in our nation’s capitol.

This document is a primer on industrial biotechnology.

President Obama has said, “the Administration will develop a National Bioeconomy Blueprint detailing steps to harness biological research innovations to address national challenges in health, food, energy, and the environment.”


February3, 2012


L. Daniel Mullaney

Assistant U.S. TradeRepresentative for Europeand the MiddleEast

Officeof theU.S. TradeRepresentative

600 17th Street NW Washington, DC 20508

Re: U.S.-EU HighLevel Working GrouponJobs andGrowth

Industrial biotechnology covers the application of biotechnology-based tools to traditional industrial processes (“bioprocessing”) and the manufacturing of bio-based products (such as fuels, chemicals and plastics) from renewable feedstocks.

BIO CEO & Investor Conference will be held February 13-14 in New York City.

Check out all of the everyday products you use that are now made from industrial biotechnology processes, which benefit you and reduce impact on the environment.

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome Sciences and Chair of BIO’s Board of Directors, recently hosted a media briefing to recap our advocacy accomplishments in 2011 and lay out BIO’s policy priorities for 2012.

Drugs approved with companion diagnostic tests represent the next wave of personalized medicine and have the potential to significantly improve patient outcomes.

Industrial & Environmental — Develops biotechnology industry policy on environmental and industrial biotechnology issues, promotes the use of industrial enzymes, conversion of biomass to energy and chemicals, and innovative clean up technologies.

BIO has long supported responsible and ethical testing, protection of individual privacy and genetic information, and regulatory systems that best serve humanity and advance research into new treatments for patients, regardless of where research is conducted.

BIO Asia will be held January 31 – February 1, 2012 in Osaka, Japan.

The challenge of conversion of biomass – particularly lignocellulosic biomass and agricultural waste – into chemicals, materials and fuels is being approached in multiple directions and a slew of technologies are now being developed, tested and deployed in semicommercial or pilot stage.

The timing for building a biobased economy as an option to the current petroleum-based one, to provide fuels, chemicals, materials and energy sustainably for the long term future cannot be better.

Harnessing microbes to change the world, one process at a time.

Biotechnology continues to hold the greatest promise to address many of the most critical issues facing our world.

What does the future hold for the biotechnology industry in Japan? The Japanese government has made great strides to boost biotech within its borders.

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

It’s time for us to embrace science, educate ourselves on its benefits, and encourage – not impede – forward thinking. Our future might depend on it!

BioMalaysia 2011 and 2011 Pacific Rim Summit on Industrial Biotechnology and Bioenergy were held jointly in Kuala Lumpur Nov. 21-23.

Congress has the opportunity to help speed lifesaving cures and treatments to patients by removing burdens to innovation in our industry.

Jobs and salaries in this industry have substantially grown in the past ten years. To date, there are more than 47,000 bioscience companies and 1.4 million workers in the United States.